Selective GI & Liver Pathology Fellowship
The Gastrointestinal and Liver Pathology program is a one-year fellowship that provides comprehensive training in diagnostic gastrointestinal, pancreatic, and hepatobiliary pathology at UT MD Anderson, one of the world’s leading cancer centers. Offered by the Department of Pathology, fellows gain extensive experience evaluating a broad spectrum of neoplastic and non-neoplastic diseases through high-volume surgical pathology and consultation services while working closely with multidisciplinary oncology teams.
The Gastrointestinal and Liver Pathology Section evaluates more than 20,000 gastrointestinal, pancreatic, and hepatobiliary specimens annually, including complex surgical resection specimens, mucosal biopsies, liver biopsies and referral consultation cases from outside institutions. Fellows participate in daily diagnostic sign-out sessions with subspecialty faculty, reviewing both in-house surgical pathology material and complex referral cases that require specialized diagnostic expertise.
Throughout the fellowship, trainees rotate through clinical services and develop expertise in the gross evaluation and tissue sampling of complex surgical specimens, as well as the interpretation of histologic findings and ancillary studies. Fellows gain hands-on experience integrating immunohistochemistry, molecular diagnostics and prognostic biomarker testing into the diagnostic evaluation of gastrointestinal and hepatobiliary diseases.
Fellows also participate in clinical conferences with specialists in gastroenterology and hepatology, contributing to discussions that guide patient management.
The program also offers extensive opportunities for scholarly activity across clinical, translational, and basic science research. Fellows are encouraged to collaborate with faculties on research projects related to gastrointestinal and hepatobiliary diseases, including clinicopathologic studies, biomarker discovery and translational oncology initiatives. Each fellow is expected to complete at least one research project during the fellowship year.
A Letter from our Program Director
Welcome to the Gastrointestinal & Liver Pathology Fellowship Program. We are proud to offer rigorous and rewarding training experience within the nation’s leading cancer center. Complemented by close mentorship from nationally and internationally recognized faculties, you can gain exposure to more than 20,000 gastrointestinal, pancreatic, and hepatobiliary specimens, including complex surgical resections, mucosal biopsies, liver biopsies, and referral consultation cases from institutions across the United States and internationally. Our program also offers abundant opportunities for research and professional development. Our mission is to train the next generation of academic and clinical leaders in gastrointestinal pathology through mentorship, innovation and excellence in patient care. We seek motivated applicants who are dedicated to developing outstanding diagnostic skills, committed to clinical excellence, and eager to strengthen communication and collaboration with clinical teams. Thank you for your interest in our program; we look forward to learning more about you during the application process.
Sincerely,
Feng Yin, M.D., Ph.D.
Program Director, Selective Gastrointestinal & Liver Pathology
Associate Professor, Pathology, Anatomical
Current Fellow
Chenxu Shi, M.D., Ph.D.
Training at UT MD Anderson has given me exposure to an extraordinary spectrum of gastrointestinal pathology and the opportunity to learn from leaders in the field. The faculty are dedicated to fellow education and are always generous with their time and expertise while on service. The broad variety of cases and supportive learning environment have made this an incredibly rewarding experience. Houston has also been a great place to live, thanks to its diversity, excellent restaurants and vibrant culture.
Our Alumni
2025-26
Kiran Madwani, M.B.B.S.
2024-25
Shaimaa Elzamly, M.D., Ph.D.
2023-24
Karen Nahmod, M.D., Ph.D.
Oluwaseyi Olayinka, M.D.
2022-23
Mehran Taherian, M.D.
2021-22
Zongshan Lai, M.D., Ph.D.
Yi Tat Tong, D.O.
2020-21
Dongguang Wei, M.D., Ph.D.
2019-20
Jamie Lombardo, M.D.
Teddy Nagaria, M.D., Ph.D.
2018-19
Wenyi Luo, M.D., Ph.D.
2017-18
Rashmi Samdani, M.D.
2016-17
Deyali Chatterjee, M.D.
2015-16
Atin Agarwal, M.D.
2014-15
Sun Mi Lee, M.D.
2013-14
Michael Huba, M.D.
2012-13
Stuti Shroff, M.D., Ph.D.
2011-12
Qing Zhao, M.D.
Wai Chin (Tim) Foo, M.D.
2010-11
Jeannelyn Estrella, M.D.
2009-10
Angela Bartley, M.D.
2008-09
Camtu Do Nguyen Truong, M.D.
Contact Information
Feng Yin, M.D., Ph.D.
Program Director, Gastrointestinal and Liver Pathology Fellowship
Division of Pathology & Laboratory Medicine
UT MD Anderson Cancer Center
1515 Holcombe Blvd., Unit 085
Houston, TX 77030
For inquiries, please contact:
Kareen E. Chin, Ed.D.
Director, Division Education Administration
Division of Pathology & Laboratory Medicine
Phone: 713-792-3108
Fax: 713-745-0789
Email: pathology-fellowship@mdanderson.org
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.
Our Labs
Learn more about our faculty and research taking place in our labs.
Conferences
View conferences available for continuing education credit.